A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans.

[1]  S. Nelson,et al.  A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan. , 2009, American journal of human genetics.

[2]  Y. Tegner,et al.  Familial osteochondritis dissecans associated with early osteoarthritis and disproportionate short stature. , 2008, Osteoarthritis and cartilage.

[3]  David M. Evans,et al.  Genome-wide association analysis identifies 20 loci that influence adult height , 2008, Nature Genetics.

[4]  F. Nicholas,et al.  Bulldog dwarfism in Dexter cattle is caused by mutations in ACAN , 2007, Mammalian Genome.

[5]  B. Olsen,et al.  Lessons from genetic forms of osteoarthritis for the pathogenesis of the disease. , 2007, Osteoarthritis and cartilage.

[6]  B. Ytrehus,et al.  Etiology and Pathogenesis of Osteochondrosis , 2007, Veterinary pathology.

[7]  P. Beighton,et al.  A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis. , 2005, American journal of human genetics.

[8]  D. Logan,et al.  Structural basis for the interactions between tenascins and the C-type lectin domains from lecticans: evidence for a cross-linking role for tenascins , 2004 .

[9]  R. Timpl,et al.  Alternative Splicing in the Aggrecan G3 Domain Influences Binding Interactions with Tenascin-C and Other Extracellular Matrix Proteins* , 2004, Journal of Biological Chemistry.

[10]  S. Eyre,et al.  Identification of a locus for a form of spondyloepiphyseal dysplasia on chromosome 15q26.1: exclusion of aggrecan as a candidate gene , 2002, Journal of medical genetics.

[11]  M. Domowicz,et al.  Chondrodysplasias due to proteoglycan defects. , 2002, Glycobiology.

[12]  Zenzo Isogai,et al.  Versican Interacts with Fibrillin-1 and Links Extracellular Microfibrils to Other Connective Tissue Networks* , 2002, The Journal of Biological Chemistry.

[13]  P. Oefner,et al.  Denaturing high‐performance liquid chromatography: A review , 2001 .

[14]  D. Heinegård,et al.  Identification and Characterization of Asporin , 2001, The Journal of Biological Chemistry.

[15]  D Heinegård,et al.  The Proteoglycans Aggrecan and Versican Form Networks with Fibulin-2 through Their Lectin Domain Binding* , 2001, The Journal of Biological Chemistry.

[16]  H H Göring,et al.  Linkage analysis in the presence of errors I: complex-valued recombination fractions and complex phenotypes. , 2000, American journal of human genetics.

[17]  N. Schwartz,et al.  Completion of the mouse aggrecan gene structure and identification of the defect in the cmd-Bc mouse as a near complete deletion of the murine aggrecan gene , 1999, Mammalian Genome.

[18]  R. Timpl,et al.  Fibulin-1 Is a Ligand for the C-type Lectin Domains of Aggrecan and Versican* , 1999, The Journal of Biological Chemistry.

[19]  R. Fässler,et al.  Mapping of a Defined Neurocan Binding Site to Distinct Domains of Tenascin-C* , 1997, The Journal of Biological Chemistry.

[20]  R. Timpl,et al.  Binding of fibulin-1 to nidogen depends on its C-terminal globular domain and a specific array of calcium-binding epidermal growth factor-like (EG) modules. , 1997, Journal of molecular biology.

[21]  E. Ruoslahti,et al.  The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  H. Watanabe,et al.  Dwarfism and age-associated spinal degeneration of heterozygote cmd mice defective in aggrecan. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Timpl,et al.  Dimer model for the microfibrillar protein fibulin‐2 and identification of the connecting disulfide bridge , 1997, The EMBO journal.

[24]  M. Schachner,et al.  Distinct Effects of Recombinant Tenascin‐R Domains in Neuronal Cell Functions and Identification of the Domain Interacting with the Neuronal Recognition Molecule F3/11 , 1996, The European journal of neuroscience.

[25]  R. Schenck,et al.  Current Concept Review - Osteochondritis Dissecans* , 1996 .

[26]  E. Ruoslahti,et al.  The versican C-type lectin domain recognizes the adhesion protein tenascin-R. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Cheng,et al.  Structure of the human aggrecan gene: exon-intron organization and association with the protein domains. , 1995, The Biochemical journal.

[28]  C. Kozak,et al.  Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene , 1994, Nature Genetics.

[29]  N. Schwartz,et al.  cDNA cloning of chick cartilage chondroitin sulfate (aggrecan) core protein and identification of a stop codon in the aggrecan gene associated with the chondrodystrophy, nanomelia. , 1993, The Journal of biological chemistry.

[30]  P. Goetinck,et al.  Nanomelic chondrocytes synthesize, but fail to translocate, a truncated aggrecan precursor. , 1993, Journal of cell science.

[31]  D Heinegård,et al.  Structure and biology of cartilage and bone matrix noncollagenous macromolecules , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  Y. Yamada,et al.  Complete primary structure of the rat cartilage proteoglycan core protein deduced from cDNA clones. , 1987, The Journal of biological chemistry.

[33]  W. Argraves,et al.  Chondrocytes from the cartilage proteoglycan-deficient mutant, nanomelia, synthesize greatly reduced levels of the proteoglycan core protein transcript. , 1987, Developmental biology.

[34]  T. Andrew,et al.  Familial osteochondritis dissecans and dwarfism. , 1981, Acta orthopaedica Scandinavica.

[35]  B Lindén,et al.  The incidence of osteochondritis dissecans in the condyles of the femur. , 1976, Acta orthopaedica Scandinavica.

[36]  D. Heinegård,et al.  Aggregation of cartilage proteoglycans. I. The role of hyaluronic acid. , 1974, The Journal of biological chemistry.

[37]  D. Heinegård,et al.  Aggregation of Cartilage Proteoglycans III. CHARACTERISTICS OF THE PROTEINS ISOLATED FROM TRYPSIN DIGESTS OF AGGREGATES , 1974 .

[38]  J. Stougaard.  FAMILIAL OCCURRENCE OF OSTEOCHONDRITIS DISSECANS. , 1964, The Journal of bone and joint surgery. British volume.

[39]  W. E. Wilson.  Osteochondritis Dissecans: Loose Bodies in Joints. Etiology, Pathology, Treatment , 1961 .

[40]  M. Pick.  Familial osteochondritis dissecans. , 1955, The Journal of bone and joint surgery. British volume.

[41]  Mary Blackwood Porter,et al.  Annals of a Publishing House: EDINBURGH AND LONDON , 2010 .

[42]  S. Eyre,et al.  Identification of a locus for a form of spondyloepiphyseal dysplasia on chromosome 15q26.1: exclusion of aggrecan as a candidate gene. , 2005, Journal of medical genetics.

[43]  N. Camp,et al.  A Robust Multipoint Linkage Statistic (tlod) for Mapping Complex Trait Loci , 2001, Genetic epidemiology.

[44]  S. Björnsson.  Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue. , 1993, Analytical biochemistry.

[45]  D. Heinegård,et al.  Isolation and characterization of proteoglycans. , 1987, Methods in enzymology.

[46]  D. Heinegård,et al.  [17] Isolation and characterization of proteoglycans , 1987 .

[47]  S. A. Grubb,et al.  Familial multiple osteochondritis dissecans. Report of a kindred. , 1985, The Journal of bone and joint surgery. American volume.

[48]  B. Linden,et al.  OSTEOCHONDRITIS DISSECANS , 1960, The Lancet.

[49]  I. Smillie.  Osteochondritis dissecans : loose bodies in joints; etiology, pathology, treatment , 1960 .